TLR9 and STING agonists synergistically induce innate and adaptive type‐II IFN

Publisher： John Wiley & Sons Inc

E-ISSN： 1521-4141|45|4|1159-1169

ISSN： 0014-2980

Source： EUROPEAN JOURNAL OF IMMUNOLOGY, Vol.45, Iss.4, 2015-04, pp. : 1159-1169

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Type I IFN‐mediated synergistic activation of mouse and human DC subsets by TLR agonists

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 14-2980, Iss. 10, 2015-10 ,pp. : 2798-2809

John Wiley & Sons Inc

Access to resources Recommend Favorite

Type I IFN‐mediated synergistic activation of mouse and human DC subsets by TLR agonists

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 10, 2015-10 ,pp. : 2798-2809

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of in vitro Costimulation with TLR2, TLR4 and TLR9 Agonists and HIV-1 on Antigen-Presenting Cell Activation

By  

Intervirology, Vol. 58, Iss. 2, 2015-04 ,pp. : 122-129

Karger

Access to resources Recommend Favorite

TLR2/6 agonists and interferon‐gamma induce human melanoma cells to produce CXCL10

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 6, 2015-09 ,pp. : 1386-1396

John Wiley & Sons Inc

Access to resources Recommend Favorite

Postulates for validating TLR4 agonists

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 2, 2015-02 ,pp. : 356-370

John Wiley & Sons Inc

Access to resources Recommend Favorite